• Conference
  • Earn CE
  • Free Samples
  • Magazine
  • Subscribe
  • Videos
    • Recent Quotes
    My Watchlist
    Indicators
    Dental Market Index
    Markets
    Stocks
    ETFs
    Tools
    Markets:
    Overview
    News
    Currencies
    International
    Treasuries

    Viking Therapeutics, Inc. - Common Stock (NQ:VKTX)

    34.24 +0.57 (+1.69%)
    Streaming Delayed Price Updated: 2:35 PM EDT, Apr 9, 2026 Add to My Watchlist
    Quote
    Overview Detailed Quote Charting Historical Prices
    News
    All News News Headlines Press Releases
    Research
    Quarterly Reports Insider Filings Other Filings

    Price and Volume

    Detailed Quote
    Volume 1,055,163
    Open 33.25
    Bid (Size) 34.20 (400)
    Ask (Size) 34.25 (300)
    Prev. Close 33.67
    Today's Range 33.25 - 34.56
    52wk Range 18.92 - 43.15
    Shares Outstanding 99,581,693
    Dividend Yield N/A
    Chart for (: )
    Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

    Top News

    More News
    News headline image
    Better Healthcare Stock to Own in a Recession: Defensive or Growth? ↗
    The answer to the question might surprise many investors. It pays to be open-minded about risk. 
    Via The Motley Fool
    Topics Economy Energy
    News headline image
    Where Will Viking Therapeutics Stock Be in 10 Years? ↗
    There is a wide range of possibilities. 
    Via The Motley Fool

    Performance

    YTD
    -3.3%
    -3.3%
    1 Month
    +1.9%
    +1.9%
    3 Month
    +5.7%
    +5.7%
    6 Month
    +5.8%
    +5.8%
    1 Year
    +71.4%
    +71.4%

    More News

    Read More
    News headline image
    The Great Metabolic Land Grab: Why Viking and Structure Have Become Big Pharma’s 'Irresistible' Targets
    Via MarketMinute
    Topics Intellectual Property
    News headline image
    Eli Lilly Secures Landmark FDA Approval for Oral Weight-Loss Pill, Sending Shares Soaring
    Via MarketMinute
    Topics Economy
    News headline image
    2 Healthcare Stocks Wall Street Analysts Say Could Rally 60% or More ↗
    Via The Motley Fool
    News headline image
    1 Reason This Biotech Stock Could Triple Before Year-End ↗
    Via The Motley Fool
    News headline image
    Why Viking Therapeutics Stock Could Take Off Later This Year ↗
    Via The Motley Fool
    News headline image
    Goldman Sachs Bullish Forecast: 15% Increase in 2026 U.S. M&A Activity
    Via MarketMinute
    Topics Artificial Intelligence Economy Intellectual Property
    News headline image
    Small-Cap Resilience: Russell 2000 Surges 3% as Geopolitical Tensions Ease and ‘Risk-On’ Appetite Returns
    Via MarketMinute
    Topics ETFs Economy Stocks
    News headline image
    Got $1,500? Is It Better to Buy Bitcoin, or Viking Therapeutics? ↗
    Via The Motley Fool
    Topics Intellectual Property
    News headline image
    Better Weight Loss Drug Stock Buy: Eli Lilly vs Viking Therapeutics ↗
    Via The Motley Fool
    News headline image
    What to Know About This Obesity Drug Developer That Just Drew a New $7 Million Investment ↗
    Via The Motley Fool
    Topics Regulatory Compliance
    News headline image
    3 Companies at the Forefront of the GLP-1 Pill Wars ↗
    Via MarketBeat
    News headline image
    Here's Why Viking Therapeutics Stock Recovered and Can Soar 2026 ↗
    Via The Motley Fool
    News headline image
    VKTX Stock Extends Red-Hot Streak: Insider Scoops Up Shares As Multiple Phase 3 Trials Loom This Year In Obesity Race ↗
    Via Stocktwits
    News headline image
    The Great Rotation: Russell 2000 Surges as Investors Flee Overstretched Tech Giants
    Via MarketMinute
    Topics Artificial Intelligence Bankruptcy ETFs
    News headline image
    Viking CEO Sees Its Obesity Drug Beating Novo's Wegovy In Weight Loss ↗
    Via Stocktwits
    News headline image
    The $1.35 Trillion Wall: Why Small-Caps are Faltering as the S&P 500 Defies Gravity
    Via MarketMinute
    Topics Artificial Intelligence Bonds Economy
    News headline image
    Forget AI Stocks: This Potentially Disruptive Biotech Could Soar By 181%, According to Wall Street ↗
    Via The Motley Fool
    Topics Artificial Intelligence
    News headline image
    The Valuation Reset: A Deep-Dive into Novo Nordisk (NVO) in 2026
    Via Finterra
    Topics Economy Intellectual Property
    News headline image
    Viking Therapeutics: The High-Stakes Weight Loss Contender ↗
    Via MarketBeat
    News headline image
    Eli Lilly Just Took 2 Major Steps Forward in the Billion-Dollar Obesity Drug Market. Here's What You Need to Know. ↗
    Via The Motley Fool
    News headline image
    Got $5,000? Viking Therapeutics Might Be a Weight‑Loss Drug Moon Shot in the Making. ↗
    Via The Motley Fool
    News headline image
    Novo Nordisk Shares Tumble 15.1% After CagriSema Fails to Topple Eli Lilly in Head-to-Head Trial
    Via MarketMinute
    News headline image
    Why Viking Therapeutics Stock Is Up More Than 9% Today ↗
    Via The Motley Fool

    Frequently Asked Questions

    Is Viking Therapeutics, Inc. - Common Stock publicly traded?
    Yes, Viking Therapeutics, Inc. - Common Stock is publicly traded.
    What exchange does Viking Therapeutics, Inc. - Common Stock trade on?
    Viking Therapeutics, Inc. - Common Stock trades on the Nasdaq Stock Market
    What is the ticker symbol for Viking Therapeutics, Inc. - Common Stock?
    The ticker symbol for Viking Therapeutics, Inc. - Common Stock is VKTX on the Nasdaq Stock Market
    What is the current price of Viking Therapeutics, Inc. - Common Stock?
    The current price of Viking Therapeutics, Inc. - Common Stock is 34.24
    When was Viking Therapeutics, Inc. - Common Stock last traded?
    The last trade of Viking Therapeutics, Inc. - Common Stock was at 04/09/26 02:35 PM ET
    What is the market capitalization of Viking Therapeutics, Inc. - Common Stock?
    The market capitalization of Viking Therapeutics, Inc. - Common Stock is 3.41B
    How many shares of Viking Therapeutics, Inc. - Common Stock are outstanding?
    Viking Therapeutics, Inc. - Common Stock has 3B shares outstanding.
    Stock Quote API & Stock News API supplied by www.cloudquote.io
    Quotes delayed at least 20 minutes.
    By accessing this page, you agree to the Privacy Policy and Terms Of Service.
    © 2025 FinancialContent. All rights reserved.